Engineer position – Epigenetic-based therapies to fight infectious diseases (France)

Engineer position – Epigenetic-based therapies to fight infectious diseases (France)

18 February 2022

Project and Consortium description

An engineer position is available to join an interdisciplinarity consortium, located in theParisarea, to study the interplay between epigenetic regulation and infectious diseases. Our objective is to find new therapeutic approaches to fight infection using epigenetic drugs. Our consortium combines expertise in thebiology and epigenetics of infection(5 teams), inproteomics(1 team) and indrug-designand medicinal chemistry of epigenetics (2 teams).

The partners are internationally-oriented research structures, located at thePasteur Institute(6 laboratories),University of Paris(1 laboratory) andUniversity Paris Saclay(1 laboratory).

The strengths of the consortium are: (1) a strong track-record showing that pathogens modulate host epigenetic mechanisms; (2) considerable resources generated by medicinal chemists; (3) in-depth expertise on seven biological models, from in vitro and in cellulo to in vivo models. The research environment includes state-of-the-art equipment and facilities for the project. Salaries are funded for at least two years and will be adjusted according to the experience of the candidate.

Requirements

We are seeking highly-qualified and motivated candidates, with a strong background in the epigenetics or proteomics. We also expect good leadership skills, good English language skills, and a commitment to team science.

Selection process

Starts December 2021 and will be continued until staffing (expected start dates from February to June 2022).To apply, please submit(i) a motivation letter, (ii) a full CV including a publication list, and (iii) the contact address of three referees.Please add the reference “Position TheraEpi” in your email header.

TheEpigenetics and Cellular Microbiologylab, INRAE, Université Paris Saclay, which studies the interactions between the Gram-positive Listeria monocytogenes bacterium and mammalian cells.